Accessibility Menu
C21 Investments logo

C21 Investments(OTC) CXXIF

Current Price$0.20
Market Cap$44.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-18%
5 Year-75%
1 Year-1%
1 Month-19%
C21 Investments last closing stock price
MetricPriceDate
Last closeUSD 0.202026-07-24
C21 Investments stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-8.65%USD 0.222026-07-17
1 month-19.17%USD 0.252026-06-24
3 month-28.05%USD 0.282026-04-24
Year to date-46.78%USD 0.392025-12-31
1 year-0.92%USD 0.212025-07-24
3 year-26.82%USD 0.282023-07-25
5 year-75.39%USD 0.832021-07-23
Since inception-18.04%USD 0.252011-10-12

C21 Investments Financials at a Glance

Market Cap

$44.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$32.64M

Net Income (TTM)

-$3.23M

EPS (TTM)

-$0.02

P/E Ratio

-9.27

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$0.20

Volume

28,850

Open

$0.21

Previous Close

$0.20

Daily Range

$0.20 - $0.22

52-Week Range

$0.19 - $0.54

Estimated Earnings Date

Jul 30, 2026

CXXIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About C21 Investments

C21 Investments Inc. operates as a fully integrated cannabis enterprise, overseeing the cultivation, processing, distribution, and retail sale of cannabis and hemp-derived consumer goods throughout the United States. Founded in 1987 and headquartered in Vancouver, Canada, the company offers a diverse product line and also provides payroll and benefits administration services.

Products and Services
  • Pre-packaged and bulk flower products
  • Vape cartridges and concentrated extracts
  • Ingestible items and topical applications
Growth Outlook
  • Revenue increased to $7.35 million in Q1 2026
  • Gross profit margin improved to 37.5% in Q1 2026
  • Operating income reached $481,577 in Q1 2026
Financial Highlights
  • Trailing twelve months (TTM) revenue of $32.5 million
  • Net income for Q1 2026 was -$1.37 million
  • Current ratio stands at 1.30, indicating liquidity strength
C21 Investments Inc. has positioned itself as a significant player in the cannabis industry, with a comprehensive approach to product offerings and services. The recent quarterly performance shows promising growth, particularly in revenue and gross profit margins, which are critical indicators of operational efficiency. Despite facing challenges reflected in net income figures, the company maintains a solid current ratio, suggesting a healthy liquidity position. The diverse product range and strategic focus on both cannabis and hemp-derived goods provide a robust foundation for future growth.
AI Generated • Jul 22, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

110

CEO

Sonny Newman

Website

www.cxxi.ca

Headquarters

Vancouver, BC V6B 1G1, CA

CXXIF Financials

Key Financial Metrics (TTM)

Gross Margin

39.13%

Operating Margin

6.99%

Net Income Margin

-9.91%

Return on Equity

-11.98%

Return on Capital

5.99%

Return on Assets

-5.83%

Earnings Yield

-10.79%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

218.68M

Volume

28.85K

Avg. Volume

57.41K

Financials (TTM)

Gross Profit

$12.24M

Operating Income

$2.26M

EBITDA

$4.30M

Operating Cash Flow

$1.35M

Capital Expenditure

-$243.68K

Free Cash Flow

$1.11M

Cash & ST Invst.

$2.24M

Total Debt

$10.54M

C21 Investments Performance Analysis

C21 Investments annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20242024-01-31USD 28,285,200-2.1%
20242024-03-31USD 26,789,700-2.1%
20252025-03-31USD 30,117,88012.4%
20262026-03-31USD 32,614,5138.3%
C21 Investments sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-305.5%
Q32025-09-30-1.0%
Q42025-12-31-2.4%
Q12026-03-31-11.1%
C21 Investments annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20242024-01-31USD -0.03N/A
20242024-03-31USD -0.00N/A
20252025-03-31USD -0.035416.7%
20262026-03-31USD -0.03-16.9%
C21 Investments sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3050.8%
Q32025-09-3036.9%
Q42025-12-31-26.8%
Q12026-03-31-21.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$7.35M

-9.4%

Gross Profit

$2.76M

-24.0%

Gross Margin

37.52%

N/A

Market Cap

$44.81MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$393.05K

N/A

Employees

114

N/A

Net Income

-$1.37M

+13.5%

EBITDA

$1.09M

-19.3%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$2.24M

-14.6%

Total Debt

$10.54M

-19.8%

Accounts Receivable

$898.29K

+408.4%

Inventory

$4.61M

+13.7%

Long Term Debt

$9.17M

-12.5%

Short Term Debt

$1.37M

-48.7%

Return on Assets

-5.83%

N/A

Return on Invested Capital

4.65%

N/A

Free Cash Flow

$260.71K

-42.9%

Operating Cash Flow

$402.03K

-17.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VEXTFVext Science, Inc.
$0.18+1.29%
MRMDMariMed Inc.
$0.07+0.00%
ELIXFElixxer Ltd.
$0.03+0.00%
DXBRFBellRock Brands Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
STAKStak
$9.27+6.02%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$31.27-0.14%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.00-0.03%

Questions About CXXIF

What is the current price of C21 Investments?

C21 Investments is trading at $0.20 per share.

What is the 52-week range for C21 Investments?

Over the past 52 weeks, C21 Investments has traded between $0.19 and $0.54.

How much debt does C21 Investments have?

As of the most recent reporting period, C21 Investments reported total debt of $10.50M.

How much cash does C21 Investments have on hand?

C21 Investments reported $2.23M in cash and cash equivalents in its most recent financial results.

What is C21 Investments’s dividend yield?

C21 Investments does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services